Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04256395Completed

Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19

Role: collaborator

NCT02694445Completed

Monetary Cost of Alzheimer's Disease in China

Role: collaborator

NCT04096872Unknown

Clinical Application of Laparo-endoscopic Single-site Surgery and Natural Orifice Transluminal Endoscopic in Gynecology

Role: collaborator

NCT03011879Unknown

China STEMI Care Project Phase 2

Role: collaborator

NCT01307410Unknown

A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China

Role: collaborator

NCT01549067Unknown

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Role: lead

All 6 trials loaded